Selman Uranues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Selman Uranues has a total of 363 co-authors. Here are the top co-authors by number of shared publications:
- Abe Fingerhut
Department of General Surgery Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
12 shared publications Viktor Justin
Medical University of Graz
6 shared publicationsAbe Fingerhut
Section for Surgical Research, Medical University of Graz, Graz, Austria
5 shared publicationsG. Tomasch
5 shared publicationsMichael D. Pasquale
4 shared publicationsAbraham Fingerhut
Medical University of Graz
3 shared publications
Latest Publications
- Open Access
- 14 January 2026
- Published by Springer Nature in European Surgery
- Vol. 58 (5) , 1-9
Laparoscopic and robotic surgery in the elderly—is there a difference in outcomes?
Summary: Background: As populations age, the number of older adults undergoing major abdominal surgery increases. Age alone poorly predicts outcomes; measures of physiological reserve and frailty are more robust parameters. Minimally invasive surgery (MIS), a general term including laparoscopic (LS) and increasingly robot-assisted surgery (RAS), may reduce surgical stress and improve recovery, but their relative benefits in elderly cohorts remain variably defined. Methods: We conducted a narrative review of PubMed, emphasizing meta-analyses and propensity score-matched cohort studies comparing LS, RAS, and open approaches in older adults across common visceral indications. No additional statistical analyses were performed. Results: Laparoscopic surgery reduces surgical stress and is consistently associated with reduced blood loss, faster bowel recovery, a shorter length of hospital stay, and lower postoperative morbidity versus open surgery, with adequate oncologic results. Frailty—not age—best stratifies risk and correlates with mortality, complications, delirium, and prolonged hospitalization. Evidence for RAS in the elderly is growing; it generally demonstrates feasibility and similar results to laparoscopy, with a tendency toward lower blood loss and shorter stays in selected procedures, counterbalanced by longer operative times associated with a higher rate of postoperative pulmonary complications. High-quality comparative data specific to frail older patients remain limited. Conclusion: Advanced age alone should not exclude MIS. When oncologically and technically feasible within an acceptable operative time, MIS should also be the standard approach in elderly patients. Frailty assessment should guide decision-making. The existing data on RAS are promising but require further geriatric-focused studies to reach definitive conclusions.
- 14 January 2026
- Published by Springer Nature in European Surgery
- Vol. 58 (5) , 1-9
Open AccessLaparoscopic and robotic surgery in the elderly—is there a difference in outcomes?
Summary: Background: As populations age, the number of older adults undergoing major abdominal surgery increases. Age alone poorly predicts outcomes; measures of physiological reserve and frailty are more robust parameters. Minimally invasive surgery (MIS), a general term including laparoscopic (LS) and increasingly robot-assisted surgery (RAS), may reduce surgical stress and improve recovery, but their relative benefits in elderly cohorts remain variably defined. Methods: We conducted a narrative review of PubMed, emphasizing meta-analyses and propensity score-matched cohort studies comparing LS, RAS, and open approaches in older adults across common visceral indications. No additional statistical analyses were performed. Results: Laparoscopic surgery reduces surgical stress and is consistently associated with reduced blood loss, faster bowel recovery, a shorter length of hospital stay, and lower postoperative morbidity versus open surgery, with adequate oncologic results. Frailty—not age—best stratifies risk and correlates with mortality, complications, delirium, and prolonged hospitalization. Evidence for RAS in the elderly is growing; it generally demonstrates feasibility and similar results to laparoscopy, with a tendency toward lower blood loss and shorter stays in selected procedures, counterbalanced by longer operative times associated with a higher rate of postoperative pulmonary complications. High-quality comparative data specific to frail older patients remain limited. Conclusion: Advanced age alone should not exclude MIS. When oncologically and technically feasible within an acceptable operative time, MIS should also be the standard approach in elderly patients. Frailty assessment should guide decision-making. The existing data on RAS are promising but require further geriatric-focused studies to reach definitive conclusions.
- 1 January 2023
- Published by Springer Nature
- p. 715-719
Approach to Perioperative Nutritional Support in Penetrating Trauma
- 1 January 2023
- Published by Springer Nature
- p. 715-719
Approach to Perioperative Nutritional Support in Penetrating Trauma
- Open Access
- 14 August 2022
- Published by Springer Nature in BMC Surgery
- Vol. 22 (1) , 1-7
Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding
Background: Adjunct hemostats can be of use in certain surgical settings. We compared the effectiveness of two hemostats, Hemopatch® and Surgicel® Original in controlling bleeding from liver lesions in an experimental model. Methods: Control of grades 1 (mild) and 2 (moderate) bleeding (according to the Validated Intraoperative Bleeding [VIBe] SCALE) was assessed for 10 min after Hemopatch® (n = 198) or Surgicel® Original (n = 199) application on 397 liver surface lesions. The primary endpoint was hemostatic success (reaching VIBe SCALE grade 0 at 10 min). The secondary endpoint was time to hemostasis (time to reach and maintain grade 0). A generalized linear mixed model and an accelerated failure time model were used to assess the primary and secondary endpoints, respectively. Results: The overall hemostatic success rate of Hemopatch® was statistically significantly superior to that of Surgicel® Original (83.8% versus 73.4%; p = 0.0036; odds ratio [OR] 2.38, 95% confidence interval [CI] 1.33–4.27) and time to hemostasis was reduced by 15.9% (p = 0.0032; 95% CI 0.749–0.944). Grade 2 bleeds treated with Hemopatch® had statistically significantly higher hemostatic success (71.7% versus 48.5%; p = 0.0007; OR 2.97, 95% CI 1.58–5.58) and shorter time to hemostasis (49.6% reduction, p = 3.6 × 10–8); differences for grade 1 bleeds (hemostatic success rate or time to hemostasis) were not statistically significant. Conclusions: Hemopatch® provided better control of VIBe SCALE bleeding compared to Surgicel® Original for Grade 2 bleeds in this porcine model, highlighting the importance of choosing a suitable hemostat to optimize control of bleeding during surgery.
- 14 August 2022
- Published by Springer Nature in BMC Surgery
- Vol. 22 (1) , 1-7
Open AccessEffectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding
Background: Adjunct hemostats can be of use in certain surgical settings. We compared the effectiveness of two hemostats, Hemopatch® and Surgicel® Original in controlling bleeding from liver lesions in an experimental model. Methods: Control of grades 1 (mild) and 2 (moderate) bleeding (according to the Validated Intraoperative Bleeding [VIBe] SCALE) was assessed for 10 min after Hemopatch® (n = 198) or Surgicel® Original (n = 199) application on 397 liver surface lesions. The primary endpoint was hemostatic success (reaching VIBe SCALE grade 0 at 10 min). The secondary endpoint was time to hemostasis (time to reach and maintain grade 0). A generalized linear mixed model and an accelerated failure time model were used to assess the primary and secondary endpoints, respectively. Results: The overall hemostatic success rate of Hemopatch® was statistically significantly superior to that of Surgicel® Original (83.8% versus 73.4%; p = 0.0036; odds ratio [OR] 2.38, 95% confidence interval [CI] 1.33–4.27) and time to hemostasis was reduced by 15.9% (p = 0.0032; 95% CI 0.749–0.944). Grade 2 bleeds treated with Hemopatch® had statistically significantly higher hemostatic success (71.7% versus 48.5%; p = 0.0007; OR 2.97, 95% CI 1.58–5.58) and shorter time to hemostasis (49.6% reduction, p = 3.6 × 10–8); differences for grade 1 bleeds (hemostatic success rate or time to hemostasis) were not statistically significant. Conclusions: Hemopatch® provided better control of VIBe SCALE bleeding compared to Surgicel® Original for Grade 2 bleeds in this porcine model, highlighting the importance of choosing a suitable hemostat to optimize control of bleeding during surgery.
- 7 January 2022
- Published by Wiley in World Journal of Surgery
- Vol. 46 (5) , 996-997
Inspirational Women in Surgery: Hildegunde Piza‐Katzer; Professor Emeritus of Plastic and Reconstructive Surgery in Austria
- 7 January 2022
- Published by Wiley in World Journal of Surgery
- Vol. 46 (5) , 996-997
Inspirational Women in Surgery: Hildegunde Piza‐Katzer; Professor Emeritus of Plastic and Reconstructive Surgery in Austria
- 30 March 2021
- Published by Springer Nature
- p. 457-461
Laparoscopic Approaches to Emergency General Surgery
- 30 March 2021
- Published by Springer Nature
- p. 457-461
Laparoscopic Approaches to Emergency General Surgery
- 16 March 2021
- Published by Springer Nature
- p. 15-21
Minimally Invasive Procedures and Prophylactic Surgery
- 16 March 2021
- Published by Springer Nature
- p. 15-21
Minimally Invasive Procedures and Prophylactic Surgery
- Open Access
- 10 February 2021
- Published by Wolters Kluwer Health in Annals of Surgery Open
- Vol. 2 (1) , e033
Clinical Impact of Stump Closure Reinforced With Hemopatch on the Prevention of Clinically Relevant Pancreatic Fistula After Distal Pancreatectomy: A Multicenter Randomized Trial
Introduction: Postoperative pancreatic fistula (POPF) is the most dreaded complication after distal pancreatectomy (DP). This multicenter randomized trial evaluated the efficacy, safety, and tolerance of Hemopatch in preventing clinically relevant (grades B/C according to the ISGPS classification) POPF after DP. Material and methods: After stump closure, patients were randomized to affix Hemopatch to the stump or not. Statistical significance was set at 0.025. Clinical significance was defined as the number of patients needed to treat (NNT) to avoid 1 B/C POPF. Results: Of 631 eligible patients, 360 were randomized and 315 analyzed per protocol (155 in the standard closure group; 160 in the Hemopatch group). The rates of B/C POPF (the primary endpoint) were 23.2% and 16.3% (P = 0.120), while the number of patients with 1 or more complications (including patients with B/C POPF) was 34.8% and 24.4% (P = 0.049) in the standard and Hemopatch groups, respectively. In patients with hand-sewn stump and main duct closure, the rates were 26.2% versus 10.0% (P = 0.014) and 23.3% versus 7.7% (P = 0.015) in the standard and Hemopatch groups, respectively. The NNT in these 2 subgroups was 6 and 6.4, respectively. Conclusion: The results of the first randomized trial evaluating Hemopatch-reinforced pancreatic stump after DP to prevent type B/C POPF do not allow us to conclude that the risk of B/C POPF was lower. Based on the NNT, however, routine use of Hemopatch after DP may result in fewer complications (including POPF) overall, especially in cases with hand-sewn closure of the pancreatic stump or main pancreatic duct.
- 10 February 2021
- Published by Wolters Kluwer Health in Annals of Surgery Open
- Vol. 2 (1) , e033
Open AccessClinical Impact of Stump Closure Reinforced With Hemopatch on the Prevention of Clinically Relevant Pancreatic Fistula After Distal Pancreatectomy: A Multicenter Randomized Trial
Introduction: Postoperative pancreatic fistula (POPF) is the most dreaded complication after distal pancreatectomy (DP). This multicenter randomized trial evaluated the efficacy, safety, and tolerance of Hemopatch in preventing clinically relevant (grades B/C according to the ISGPS classification) POPF after DP. Material and methods: After stump closure, patients were randomized to affix Hemopatch to the stump or not. Statistical significance was set at 0.025. Clinical significance was defined as the number of patients needed to treat (NNT) to avoid 1 B/C POPF. Results: Of 631 eligible patients, 360 were randomized and 315 analyzed per protocol (155 in the standard closure group; 160 in the Hemopatch group). The rates of B/C POPF (the primary endpoint) were 23.2% and 16.3% (P = 0.120), while the number of patients with 1 or more complications (including patients with B/C POPF) was 34.8% and 24.4% (P = 0.049) in the standard and Hemopatch groups, respectively. In patients with hand-sewn stump and main duct closure, the rates were 26.2% versus 10.0% (P = 0.014) and 23.3% versus 7.7% (P = 0.015) in the standard and Hemopatch groups, respectively. The NNT in these 2 subgroups was 6 and 6.4, respectively. Conclusion: The results of the first randomized trial evaluating Hemopatch-reinforced pancreatic stump after DP to prevent type B/C POPF do not allow us to conclude that the risk of B/C POPF was lower. Based on the NNT, however, routine use of Hemopatch after DP may result in fewer complications (including POPF) overall, especially in cases with hand-sewn closure of the pancreatic stump or main pancreatic duct.
- 1 September 2020
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 75 (9) , 549-550
Prophylactic Salpingectomy for Prevention of Ovarian Cancer at the Time of Elective Laparoscopic Cholecystectomy
(Abstracted from BJS 2020;107:519–524) The majority of ovarian cancers are now believed to originate in the fimbriae of the fallopian tubes as serous tubal intraepithelial carcinomas (STICs). Removal of the fallopian tubes (salpingectomy) has been associated with a reduced risk of developing ovarian cancer, leading to gynecologic societies recommending prophylactic salpingectomy at the time of pelvic surgery in appropriate women.
- 1 September 2020
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 75 (9) , 549-550
Prophylactic Salpingectomy for Prevention of Ovarian Cancer at the Time of Elective Laparoscopic Cholecystectomy
(Abstracted from BJS 2020;107:519–524) The majority of ovarian cancers are now believed to originate in the fimbriae of the fallopian tubes as serous tubal intraepithelial carcinomas (STICs). Removal of the fallopian tubes (salpingectomy) has been associated with a reduced risk of developing ovarian cancer, leading to gynecologic societies recommending prophylactic salpingectomy at the time of pelvic surgery in appropriate women.
- Open Access
- 24 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-10
Quality of life in uncomplicated recurrent diverticulitis: surgical vs. conservative treatment
Elective sigmoid colectomy for recurrent uncomplicated diverticulitis remains controversial and is decided on an individual basis. Eighty patients treated conservatively (44 patients) or by elective surgery (36 patients) for recurrent uncomplicated diverticulitis were contacted and assessed for quality of life. The mean difference in quality of life scores was greater after surgery (overall + 2.14%, laparoscopic resection +4.95%, p = 0.36 and p = 0.11, respectively) as compared to conservative management. Female patients undergoing laparoscopic resection had statistically significantly higher quality of life scores than women treated conservatively (+8.98%; p = 0.049). Twenty-eight of 29 responding patients stated that they were highly satisfied and would have the operation done again. Elective sigmoidectomy is a valid treatment option for recurrent uncomplicated diverticulitis in terms of quality of life. Quality of life improved most if surgery was performed laparoscopically, especially in women.
- 24 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-10
Open AccessQuality of life in uncomplicated recurrent diverticulitis: surgical vs. conservative treatment
Elective sigmoid colectomy for recurrent uncomplicated diverticulitis remains controversial and is decided on an individual basis. Eighty patients treated conservatively (44 patients) or by elective surgery (36 patients) for recurrent uncomplicated diverticulitis were contacted and assessed for quality of life. The mean difference in quality of life scores was greater after surgery (overall + 2.14%, laparoscopic resection +4.95%, p = 0.36 and p = 0.11, respectively) as compared to conservative management. Female patients undergoing laparoscopic resection had statistically significantly higher quality of life scores than women treated conservatively (+8.98%; p = 0.049). Twenty-eight of 29 responding patients stated that they were highly satisfied and would have the operation done again. Elective sigmoidectomy is a valid treatment option for recurrent uncomplicated diverticulitis in terms of quality of life. Quality of life improved most if surgery was performed laparoscopically, especially in women.